| Physical, chemical, and in vitro toxicological characterization of nanoparticles in chemical mechanical planarization suspensions used in the semiconductor industry: towards … D Speed, P Westerhoff, R Sierra-Alvarez, R Draper, P Pantano, ... Environmental Science: Nano 2 (3), 227-244, 2015 | 84 | 2015 |
| RNA fibers as optimized nanoscaffolds for siRNA coordination and reduced immunological recognition L Rackley, JM Stewart, J Salotti, A Krokhotin, A Shah, JR Halman, ... Therapeutic RNA Nanotechnology, 943-969, 2021 | 71 | 2021 |
| Mucin-1-antibody-conjugated mesoporous silica nanoparticles for selective breast cancer detection in a mucin-1 transgenic murine mouse model D Dréau, LJ Moore, MP Alvarez-Berrios, M Tarannum, P Mukherjee, ... Journal of biomedical nanotechnology 12 (12), 2172-2184, 2016 | 69 | 2016 |
| Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse RM Shapiro, GC Birch, G Hu, JV Cadavid, S Nikiforow, J Baginska, AK Ali, ... The Journal of clinical investigation 132 (11), 2022 | 65 | 2022 |
| Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia H Dong, JD Ham, G Hu, G Xie, J Vergara, Y Liang, A Ali, M Tarannum, ... Proceedings of the National Academy of Sciences 119 (25), e2122379119, 2022 | 60 | 2022 |
| Cellular endocytosis and trafficking of cholera toxin B-modified mesoporous silica nanoparticles WA Walker, M Tarannum, JL Vivero-Escoto Journal of Materials Chemistry B 4 (7), 1254-1262, 2016 | 50 | 2016 |
| Combination of nucleic acid and mesoporous silica nanoparticles: optimization and therapeutic performance in vitro R Juneja, H Vadarevu, J Halman, M Tarannum, L Rackley, J Dobbs, ... Therapeutic RNA Nanotechnology, 565-604, 2021 | 46 | 2021 |
| Cytokine-induced memory-like natural killer cells for cancer immunotherapy M Tarannum, R Romee Stem Cell Research & Therapy 12 (1), 592, 2021 | 39 | 2021 |
| Activation of tumor-cell STING primes NK-cell therapy EH Knelson, EV Ivanova, M Tarannum, M Campisi, PH Lizotte, MA Booker, ... Cancer immunology research 10 (8), 947-961, 2022 | 30 | 2022 |
| Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment M Tarannum, JL Vivero-Escoto Advanced Drug Delivery Reviews 187, 114357, 2022 | 24 | 2022 |
| Innovative strategies to improve the clinical application of NK cell-based immunotherapy M Tarannum, R Romee, RM Shapiro Frontiers in Immunology 13, 859177, 2022 | 24 | 2022 |
| Advanced Nanoengineering Approach for Target‐Specific, Spatiotemporal, and Ratiometric Delivery of Gemcitabine–Cisplatin Combination for Improved Therapeutic Outcome in … M Tarannum, MA Hossain, B Holmes, S Yan, P Mukherjee, ... Small 18 (2), 2104449, 2022 | 20 | 2022 |
| The Effect of Silver Nanoparticle Size and Coating on Escherichia coli JLG Mehrdad Tajkarimi, Divya S Iyer, Mubin Tarannum, Q. Cunningham, I. Sharpe JSM Nanotechnology and Nanomedicine 2 (2), 1025, 2014 | 18 | 2014 |
| Biodegradable Silica‐Based Nanoparticles with Improved and Safe Delivery of Protoporphyrin IX for the In Vivo Photodynamic Therapy of Breast Cancer ZK Lyles, M Tarannum, C Mena, NM Inada, VS Bagnato, ... Advanced Therapeutics 3 (7), 2000022, 2020 | 16 | 2020 |
| Nanoparticle combination for precise stroma modulation and improved delivery for pancreatic cancer M Tarannum, K Holtzman, D Dreau, P Mukherjee, JL Vivero-Escoto Journal of Controlled Release 347, 425-434, 2022 | 14 | 2022 |
| Examining the cellular uptake and toxicity of engineered nanomaterials K Kosaraju, M Tarannum, S Crawford, K Garde, S Aravamudhan ECS Transactions 61 (36), 15, 2014 | 6 | 2014 |
| Activation of Tumor-Cell STING Primes NK-Cell Therapy. Cancer Immunol. Res. 2022; 10: 947–961. doi: 10.1158/2326-6066 EH Knelson, EV Ivanova, M Tarannum, M Campisi, PH Lizotte, MA Booker, ... CIR-22-0017, 0 | 6 | |
| Assessment of Change in Physicochemical Properties and Cellular Toxicity of Pre-and Post-CMP Silica Slurries K Kosaraju, S Crawford, M Tarannum, S Aravamudhan ECS Journal of Solid State Science and Technology 4 (11), P5068, 2015 | 4 | 2015 |
| Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma J Bae, S Kitayama, Z Herbert, L Daheron, K Kurata, DB Keskin, K Livak, ... Blood 143 (10), 895-911, 2024 | 3 | 2024 |
| Genetic manipulation approaches to enhance the clinical application of NK cell-based immunotherapy A Maia, M Tarannum, R Romee Stem Cells Translational Medicine 13 (3), 230-242, 2024 | 2 | 2024 |
